Bioprinting & Tissue Engineering Devices Market PDF Report 2025-2033 | Led by North America share of 42.87% in 2024

bioprinting & tissue engineering devices market size reached US$ 19.42 Billion in 2024 from US$ 17.08 Billion in 2023 and is expected to reach US$ 66.65 Billion by 2033, growing at a CAGR of 14.9% during the forecast period 2025-2033.

Get Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/bioprinting-and-tissue-engineering-devices-market?kb

United States: Recent Industry Developments

✅ November 2025: Organovo advanced its 3D bioprinting platforms for liver and kidney tissue modeling in preclinical research.

✅ October 2025: 3D Systems expanded its bioprinting solutions portfolio for regenerative medicine and pharmaceutical testing.

✅ September 2025: CELLINK strengthened partnerships with U.S. research institutes to accelerate commercialization of tissue engineering devices.

Japan: Recent Industry Developments

✅ November 2025: Fujifilm Cellular Dynamics enhanced bioprinting technologies using iPS cells for regenerative therapies.

✅ October 2025: Cyfuse Biomedical Systems advanced scaffold-free bioprinting devices for organoid and tissue regeneration research.

✅ September 2025: Japanese universities collaborated with device manufacturers to scale bioprinted tissue applications in clinical research.

GCC: Recent Industry Developments

✅ November 2025: Saudi Arabia invested in advanced bioprinting laboratories to support regenerative medicine initiatives under Vision 2030.

✅ October 2025: UAE-based healthcare research centers adopted tissue engineering devices for personalized medicine and drug testing.

✅ September 2025: Public-private partnerships in the GCC accelerated the adoption of bioprinting technologies in academic and clinical settings.

Key Players:

CELLINK, 3D Systems, Inc., CollPlant Biotechnologies Ltd., Organovo Holdings Inc., Regemat 3D, regenHU, CYFUSE BIOMEDICAL K.K., Poietis Biosystems, and ARTBioprint

Key Industry Development:

Key device launches and technology developments

1. TissueLabs launched the TissuePro extrusion‐based bioprinter in 2025, targeting regenerative medicine labs and advanced drug‐development workflows with multi‐material printing and integrated control over temperature and sterile conditions.​

2. REGEMAT 3D announced a new modular bioprinter platform in March 2025, designed for configurable printheads and stages so researchers can adapt a single system to multiple tissues, bioinks and scaffold strategies.​

3. The LusoBioMaker project introduced an open‐source, multi‐material 3D bioprinter delivering near commercial performance for under USD 900, significantly lowering the barrier to entry for academic and low‐budget labs.​

4. Auxilium Biotechnologies demonstrated space‐based bioprinting on the ISS in February 2025, successfully printing eight implantable medical devices in microgravity in two hours, highlighting new manufacturing modalities for complex implants and tissues.​

Tissue‐engineering scaffolds and integrated devices

✅ 2025 reviews emphasize "bionic" scaffolds that combine biomimetic architecture, controlled degradation and embedded bioactive cues for cartilage and osteochondral repair, using advanced fabrication methods including 3D printing and electrospinning.​

✅ New work on 3D‐printed biodegradable polymer scaffolds summarizes state‐of‐the‐art printable polymers (e.g., PLA, PLGA, PCL) and printing strategies to tune mechanics, porosity and degradation for bone, cartilage and soft‐tissue engineering.​

✅ Engineering "therapeutic scaffolds" with integrated drug‐delivery systems is a major 2025 theme, embedding controlled‐release reservoirs of growth factors, anti‐inflammatories or immunomodulators within scaffolds to improve regeneration outcomes.​

Ecosystem and application focus

1. Leading commercial players highlighted across 2025 reports include CELLINK/BICO, Organovo, Aspect Biosystems, 3D Systems, TissueLabs, REGEMAT 3D and others, often coupling hardware with proprietary bioinks and software.​

2. Main application areas remain preclinical drug testing, disease modelling, tissue patches (skin, cartilage, bone) and early organ‐scale constructs, with China and Japan singled out as high‐growth bioprinting markets through strong government and healthcare‐innovation support.

Growth Forecast Projected:

The Global Bioprinting & Tissue Engineering Devices Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Bioprinting & Tissue Engineering Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=bioprinting-and-tissue-engineering-devices-market?kb

Key Segments:

By Material: (Synthetic Materials, Natural Materials, Scaffolds, and Protein-Based Materials)

By Application: (Tissue Engineering & Regenerative Medicine, Drug Discovery, Development & Toxicology Testing, Biomedical Research & Academic Applications, Therapeutic Applications, and Others)

By End-User: (Hospitals & Clinics, Academic & Research Institutes, Biopharmaceutical Companies, and Contract Manufacturing Organizations)

Regional Analysis for Bioprinting & Tissue Engineering Devices Market:

⇥ North America led the bioprinting and tissue engineering devices market, accounting for the highest revenue share of 42.87% in 2024.

⇥ Asia Pacific is the fastest-growing region, projected to register the highest CAGR of 14.7% during the forecast period.

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8: Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/bioprinting-and-tissue-engineering-devices-market?kb

FAQ

Q1: What is the current size of the Bioprinting & Tissue Engineering Devices Market?

A: The Bioprinting & Tissue Engineering Devices Market was valued at US$ 19.42 Billion in 2024 and is forecasted to reach US$ 66.65 Billion by 2033

Q2: How rapidly will the Market expand?

A: The Bioprinting & Tissue Engineering Devices market is projected to grow at a CAGR of 14.9% between 2025 and 2033.

Unlock Free 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.